AUROPHARMA

incorporated a new wholly-owned subsidiary, Eugia Pharma Chile SpA, in Chile to expand its pharmaceutical business in South America. The company was officially incorporated on October 7, 2025, with an initial subscription of approximately USD 1,050. This move aligns with Aurobindo Pharma's strategy to diversify geographically and enhance its product offerings.